ResMed Inc. (RMD)
NYSE
225.98
+5.29 (+2.40%)
Closed
Oct 7, 2026
Day's Range
221.83228.75
52 wk Range
180.27284.87
Financial Statements - RMD - ResMed Inc.
Revenue
5.65B▲ 9.9%
Net Income
1.52B▲ 8.8%Net Margin 26.9%
EBITDA
2.17B▲ 12.9%
Free Cash Flow
1.62B▼ 1.4%
Income Statement
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|---|
| Sales | 5.65B | 5.14B | 4.68B | 4.22B | 3.57B | 3.19B |
| Cost of Goods | 2.20B | 2.09B | 2.02B | 1.86B | 1.55B | 1.35B |
| Gross Profit | 3.45B | 3.05B | 2.65B | 2.35B | 2.02B | 1.83B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.90B | 1.68B | 1.38B | 1.15B | 1B | 912.35M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -38.95M | -13.94M | -73.61M | -2.95M | -19.35M | -5.06M |
| Pre Tax Income | 1.91B | 1.67B | 1.26B | 1.10B | 960.48M | 883.66M |
| Income Tax | 396.12M | 276.84M | 243.84M | 204.10M | 181.04M | 409.15M |
| Net Income | 1.52B | 1.40B | 1.02B | 897.55M | 779.43M | 474.50M |
| EPS Basic | - | - | 6.94 | 6.12 | 5.34 | 3.27 |
| EPS Diluted | - | - | 6.92 | 6.09 | 5.3 | 3.24 |
| Basic Shares Outstanding | - | - | 147.02M | 146.76M | 146.06M | 145.31M |
| Diluted Shares Outstanding | - | - | 147.02M | 146.76M | 146.06M | 145.31M |
| Ebit | 1.90B | 1.68B | 1.31B | 1.14B | 982.79M | 912.35M |
| Ebitda | 2.17B | 1.92B | 1.59B | 1.33B | 1.19B | 1.11B |
| Net Income Continuous Operations | 1.52B | 1.40B | 1.02B | 897.55M | 779.43M | 474.50M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
